The role of microrna-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 581-586

  Teo, Mark T W ^a   Landi, Debora ^b   Taylor, Claire F ^a   Elliott, Faye ^a   Vaslin, Laurence ^c,d   Cox, David G ^e   Hall, Janet ^c,d   Landi, Stefano ^b   Bishop, D Timothy ^a   Kiltie, Anne E ^f  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c INSERM U612   (France)

^d INSTITUT CURIE   (France)

^e CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BINDING SITE; BIOINFORMATICS; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SPECIFIC SURVIVAL; CARCINOGENESIS; CLINICAL TRIAL; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PRIORITY JOURNAL; RNA BINDING; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84857926657     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr300     Document Type: Article

References (53)

1. Liu,Z. et al. (2008) MicroRNA: an emerging therapeutic target and intervention tool. Int. J. Mol. Sci., 9, 978-999.
2. Zeng,Y. et al. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA, 100, 9779-9784.
3. Brennecke,J. et al. (2005) Principles of microRNA-target recognition. PLoS Biol., 3, e85.
4. John,B. et al. (2004) Human MicroRNA targets. PLoS Biol., 2, e363.
5. Krek,A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
6. Lewis,B.P. et al. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
7. Rusinov,V. et al. (2005) MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res., 33, W696-W700.
8. Kiriakidou,M. et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev., 18, 1165-1178.
9. Zhang,L. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
10. Dyrskjot,L. et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res., 69, 4851-4860.
11. Horikawa,Y. et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin. Cancer Res., 14, 7956-7962.
12. Liu,Z. et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer, 116, 4753-4760.
13. Yang,R. et al. (2010) A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res. Treat., 121, 693-702.
14. Yu,Z. et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res., 35, 4535-4541.
15. Landi,D. et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579-584.
16. Nicoloso,M.S. et al. (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res., 70, 2789-2798.
17. Berwick,M. et al. (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl Cancer Inst., 92, 874-897.
18. Goode,E.L. et al. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1513-1530.
19. Wu,X. et al. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-6523.
20. Kiltie,A.E. (2009) Molecular epidemiology of DNA repair genes in bladder cancer. Methods Mol. Biol., 472, 281-306.
21. Stern,M.C. et al. (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res., 69, 6857-6864.
22. Tonin,P. et al. (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med., 2, 1179-1183.
23. Silva,S.N. et al. (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol., 34, 85-92.
24. Thomas,G. et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p.11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584.
25. Kawashima,A. et al. (2011) Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer. Clin. Cancer Res., 17, 2561-2569.
26. Choudhury,A. et al. (2010) MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Cancer Res., 70, 7017-7026.
27. Parliament,M.B. et al. (2010) Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin. Radiat. Oncol., 20, 232-240.
28. Sakano,S. et al. (2006) Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br. J. Cancer, 95, 561-570.
29. Choudhury,A. et al. (2008) Analysis of variants in DNA damage signalling genes in bladder cancer. BMC Med. Genet., 9, 69.
30. Moullan,N. et al. (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev., 12, 1168-1174.
31. Sak,S.C. et al. (2006) Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 2537-2541.
32. Li,Q. et al. (2009) Robust tests for single-marker analysis in case-control genetic association studies. Ann. Hum. Genet., 73, 245-252.
33. Kotwal,S. et al. (2008) Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int. J. Radiat. Oncol. Biol. Phys., 70, 456-463.
34. Petermann,E. et al. (2006) Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst), 5, 544-555.
35. Megnin-Chanet,F. et al. (2010) Targeting poly(ADP-ribose) polymerase activity for cancer therapy. Cell. Mol. Life Sci., 67, 3649-3662.
36. Audebert,M. et al. (2004) Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem., 279, 55117-55126.
37. Sarasin,A. et al. (2008) Overexpression of DNA repair genes is associated with metastasis: a new hypothesis. Mutat. Res., 659, 49-55.
38. Wang,M. et al. (2006) PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res., 34, 6170-6182.
39. Yang,H. et al. (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res., 68, 2530-2537.
40. Lu,Q. et al. (2010) MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. Urol. Oncol., 28, 635-641.
41. Catto,J.W. et al. (2009) Distinct microRNA alterations characterize highand low-grade bladder cancer. Cancer Res., 69, 8472-8481.
42. Ostenfeld,M.S. et al. (2010) miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene, 29, 1073-1084.
43. Pharoah,P.D. et al. (2011) The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin. Cancer Res., 17, 3742-3750.
44. Liang,D. et al. (2010) Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res., 70, 9765-9776.
45. Chin,L.J. et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res., 68, 8535-8540.
46. Brendle,A. et al. (2008) Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis, 29, 1394-1399.
47. Le Scodan,R. et al. (2010) DNA repair gene expression and risk of locoregional relapse in breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys., 78, 328-336.
48. Wong,T.S. et al. (2008) Mature miR-184 as potential oncogenic micro-RNA of squamous cell carcinoma of tongue. Clin. Cancer Res., 14, 2588-2592.
49. Lehmann,U. et al. (2010) Identification of differentially expressed micro-RNAs in human male breast cancer. BMC Cancer, 10, 109.
50. Li,X. et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res., 9, 824-833.
51. Zheng,D. et al. (2011) Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol., 4, 575-586.
52. Zhou,J. et al. (2010) 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol. Rep., 23, 121-128.
53. Wacholder,S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.